How far is it to take down the 10 billion "gold single" of Russian Huoxiang Zhengqi oral liquid?

On the evening of July 8, Chongqing Taiji industry (Group) Co., Ltd (Taiji Group) announced that its holding subsidiary, Taiji Group Chongqing Fuling Pharmaceutical Factory Co., Ltd., had recently received the access approval issued by the consumer protection and social welfare Supervision Bureau of the Russian Federation, which approved that the company's product Huoxiang Zhengqi oral liquid could be sold and used in Russia Taiji group said that the Huoxiang Zhengqi oral liquid won the approval of market access in Russia, marking that it can not only be sold in Russia, but also cover Belarus, Kazakhstan and other Eurasian Economic Union member countries, which will have a positive impact on the company's overseas market expansion It's far from the 10 billion "gold single" in the past media reports Taiji Group has proposed that Taiji Huoxiang Zhengqi liquid will be sold to at least 50 countries or regions in the world by 2027 At the same time, in the 10-year strategic plan of Taiji Huoxiang Zhengqi liquid, the sales volume in 2018 will reach 2 billion yuan, 5 billion yuan in 2021, and 10 billion yuan in 2027, making Taiji Huoxiang Zhengqi liquid a ten billion level "gold single product" At present, the planned sales target and the number of sales to the region are not progressing smoothly In 2018, the sales volume of Huoxiang Zhengqi oral liquid decreased, among which, the production volume of Huoxiang Zhengqi oral liquid (10ml × 5 × 120) increased by 13.95%, the sales volume decreased by 28.46% year on year; the production volume of Huoxiang Zhengqi oral liquid (10ml × 10 × 70) decreased by 14.43%, and the sales volume decreased by 10.93% In 2018, the sales revenue including tax was 1.15 billion yuan, failing to achieve the sales target of 2 billion yuan Now, Huoxiang Zhengqi oral liquid has been registered in 13 countries and regions, including Russia, Laos, Canada, Malaysia, Singapore, Mozambique, Indonesia, the United States, Brunei, Thailand, Cambodia, etc., and far from reaching the goal of marketing in at least 50 countries or regions around the world After the sales target was announced, Bai Lixi, 55, chairman of Taiji group, applied for resignation on June 18, 2019 due to job changes, and no longer held other positions in the company after resignation On July 4, Taiji Group issued a notice to elect Li Yangchun as the chairman of the ninth board of directors of the company The old leader left the stage and the new leader came on stage quickly Does this mean that Taiji Group has a long way to go to build 10 billion grade single products and break into the "100 billion yuan club" The dilemma in front of the new leader It is understood that Taiji group was listed in 1997 In 1998, Taiji Group acquired TongJunGe In 2003, Taiji Group acquired Southwest Pharmaceutical industry Through acquisition and merger of peer enterprises, Taiji group realized the development from a single production of traditional Chinese medicine into a comprehensive pharmaceutical enterprise integrated with research and development, production and sales of Western medicine, and stepped into the first echelon of pharmaceutical enterprises According to the 2018 annual report, Taiji Group achieved a revenue of 10.689 billion yuan, an increase of 21.84% year-on-year; the net profit attributable to the parent company was 700 million yuan, a decrease of 28.11% year-on-year; the non net profit deducted was a significant decrease of 230.71% year-on-year to a loss of 84 million yuan At the same time of revenue breaking through 10 billion for the first time since listing, it is faced with loss of non net profit In addition, Taiji group finally fell to 74.52% at the end of 2018 and 74.38% at the end of the first quarter of 2019 after saying goodbye to the asset liability ratio higher than 80% for six consecutive years However, Taiji group still ranked second among 176 pharmaceutical index components in the same period As a result, the new chairman of the board of directors, the long-term deduction of non net profit loss and high debt ratio has become a major problem in front of Taiji group At the same time, Taiji Group has also been criticized for its low investment in R & D At present, Taiji Group is in the process of mixed reform, and how to promote the mixed reform has become another problem in front of the new chairman On February 21 this year, Taiji Group announced that its controlling shareholder Taiji Group Co., Ltd (Taiji Co., Ltd.) plans to carry out the mixed ownership reform and introduce strategic investors as new shareholders Taiji Co., Ltd holds 33.20% of the equity of Taiji group, which is the largest shareholder Behind it is the state owned assets supervision and Administration Commission of Fuling District, Chongqing According to the announcement, the mixed reform is to implement the Chongqing municipal government's plan on deepening the reform of state-owned assets of state-owned enterprises in Chongqing On the basis of the existing state owned assets supervision and Administration Commission of Fuling District, Taiji Co., Ltd plans to introduce strategic investors as new shareholders, and the actual controllers will not change He Li, chief analyst of Guotai Junan Chongqing, believes that Taiji Group's participation in the "mixed reform" can change the current situation of "one share dominating" of state-owned assets, optimize the equity governance structure of listed companies, and improve the operating efficiency of the company; at the same time, if it can introduce advantageous enterprises to participate in the industry, it can also form a synergistic effect of resource sharing and complementary advantages with listed companies At present, there is no news about the latest progress of the mixed reform, but Bai Lixi, who accompanied Taiji for 30 years, resigned from all his posts, which is suspected by the insiders to be related to the mixed reform "Because of the adjustment of the government, the work has changed," Jiang Qian, a secretary of Taiji group, told the China times It can be seen that it is not easy to advance the mixed reform.